table of content
1 Study Coverage
1.1 Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sumatriptan
1.2.3 Zolmitriptan
1.2.4 Rizatriptan
1.2.5 Others Drug
1.3 Market by Application
1.3.1 Global Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Migraine Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Migraine Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Migraine Drugs Sales by Region
2.4.1 Global Migraine Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Migraine Drugs by Region (2023-2028)
2.5 Global Migraine Drugs Revenue by Region
2.5.1 Global Migraine Drugs Revenue by Region (2017-2022)
2.5.2 Global Migraine Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Migraine Drugs Sales by Manufacturers
3.1.1 Global Top Migraine Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Migraine Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Migraine Drugs in 2021
3.2 Global Migraine Drugs Revenue by Manufacturers
3.2.1 Global Migraine Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Migraine Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Migraine Drugs Revenue in 2021
3.3 Global Migraine Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Migraine Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Migraine Drugs Sales by Type
4.1.1 Global Migraine Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Migraine Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Migraine Drugs Sales Market Share by Type (2017-2028)
4.2 Global Migraine Drugs Revenue by Type
4.2.1 Global Migraine Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Migraine Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Migraine Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Migraine Drugs Price by Type
4.3.1 Global Migraine Drugs Price by Type (2017-2022)
4.3.2 Global Migraine Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Migraine Drugs Sales by Application
5.1.1 Global Migraine Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Migraine Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Migraine Drugs Sales Market Share by Application (2017-2028)
5.2 Global Migraine Drugs Revenue by Application
5.2.1 Global Migraine Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Migraine Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Migraine Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Migraine Drugs Price by Application
5.3.1 Global Migraine Drugs Price by Application (2017-2022)
5.3.2 Global Migraine Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Migraine Drugs Market Size by Type
6.1.1 North America Migraine Drugs Sales by Type (2017-2028)
6.1.2 North America Migraine Drugs Revenue by Type (2017-2028)
6.2 North America Migraine Drugs Market Size by Application
6.2.1 North America Migraine Drugs Sales by Application (2017-2028)
6.2.2 North America Migraine Drugs Revenue by Application (2017-2028)
6.3 North America Migraine Drugs Market Size by Country
6.3.1 North America Migraine Drugs Sales by Country (2017-2028)
6.3.2 North America Migraine Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Migraine Drugs Market Size by Type
7.1.1 Europe Migraine Drugs Sales by Type (2017-2028)
7.1.2 Europe Migraine Drugs Revenue by Type (2017-2028)
7.2 Europe Migraine Drugs Market Size by Application
7.2.1 Europe Migraine Drugs Sales by Application (2017-2028)
7.2.2 Europe Migraine Drugs Revenue by Application (2017-2028)
7.3 Europe Migraine Drugs Market Size by Country
7.3.1 Europe Migraine Drugs Sales by Country (2017-2028)
7.3.2 Europe Migraine Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Migraine Drugs Market Size by Type
8.1.1 Asia Pacific Migraine Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Migraine Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Migraine Drugs Market Size by Application
8.2.1 Asia Pacific Migraine Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Migraine Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Migraine Drugs Market Size by Region
8.3.1 Asia Pacific Migraine Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Migraine Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Migraine Drugs Market Size by Type
9.1.1 Latin America Migraine Drugs Sales by Type (2017-2028)
9.1.2 Latin America Migraine Drugs Revenue by Type (2017-2028)
9.2 Latin America Migraine Drugs Market Size by Application
9.2.1 Latin America Migraine Drugs Sales by Application (2017-2028)
9.2.2 Latin America Migraine Drugs Revenue by Application (2017-2028)
9.3 Latin America Migraine Drugs Market Size by Country
9.3.1 Latin America Migraine Drugs Sales by Country (2017-2028)
9.3.2 Latin America Migraine Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Migraine Drugs Market Size by Type
10.1.1 Middle East and Africa Migraine Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Migraine Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Migraine Drugs Market Size by Application
10.2.1 Middle East and Africa Migraine Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Migraine Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Migraine Drugs Market Size by Country
10.3.1 Middle East and Africa Migraine Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Migraine Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Endo International
11.7.1 Endo International Corporation Information
11.7.2 Endo International Overview
11.7.3 Endo International Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Endo International Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo International Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 Impax
11.9.1 Impax Corporation Information
11.9.2 Impax Overview
11.9.3 Impax Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Impax Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Impax Recent Developments
11.10 Abbott
11.10.1 Abbott Corporation Information
11.10.2 Abbott Overview
11.10.3 Abbott Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Abbott Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abbott Recent Developments
11.11 Bayer
11.11.1 Bayer Corporation Information
11.11.2 Bayer Overview
11.11.3 Bayer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bayer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bayer Recent Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Corporation Information
11.12.2 Eli Lilly Overview
11.12.3 Eli Lilly Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Eli Lilly Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Eli Lilly Recent Developments
11.13 Ethypharm
11.13.1 Ethypharm Corporation Information
11.13.2 Ethypharm Overview
11.13.3 Ethypharm Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ethypharm Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ethypharm Recent Developments
11.14 Kowa Pharmaceuticals America
11.14.1 Kowa Pharmaceuticals America Corporation Information
11.14.2 Kowa Pharmaceuticals America Overview
11.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Kowa Pharmaceuticals America Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Kowa Pharmaceuticals America Recent Developments
11.15 Winston Pharmaceuticals
11.15.1 Winston Pharmaceuticals Corporation Information
11.15.2 Winston Pharmaceuticals Overview
11.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Winston Pharmaceuticals Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Winston Pharmaceuticals Recent Developments
11.16 AstraZeneca
11.16.1 AstraZeneca Corporation Information
11.16.2 AstraZeneca Overview
11.16.3 AstraZeneca Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 AstraZeneca Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 AstraZeneca Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Migraine Drugs Industry Chain Analysis
12.2 Migraine Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Migraine Drugs Production Mode & Process
12.4 Migraine Drugs Sales and Marketing
12.4.1 Migraine Drugs Sales Channels
12.4.2 Migraine Drugs Distributors
12.5 Migraine Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Migraine Drugs Industry Trends
13.2 Migraine Drugs Market Drivers
13.3 Migraine Drugs Market Challenges
13.4 Migraine Drugs Market Restraints
14 Key Findings in The Global Migraine Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer